Jing Zhang

Co-Founder & VP, High Throughput & High Content Screening, Chengdu at Anticancer Biosciences

Dr. Zhang co-founded Anticancer Bioscience after an academic background in molecular biology in the UK. She has expertise in synthetic lethal genetic screening gained during her Ph.D. study at the University of Nottingham, UK and received postdoctoral training in the field of cellular immunity and gene editing system CRISPR at the University of St Andrews, UK.

Location

Chengdu, China

Links